Connection
Cindy O'Bryant to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications Cindy O'Bryant has written about Receptors, Vascular Endothelial Growth Factor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.015 |
|
|
|
-
Kobayashi H, Eckhardt SG, Lockridge JA, Rothenberg ML, Sandler AB, O'Bryant CL, Cooper W, Holden SN, Aitchison RD, Usman N, Wolin M, Basche ML. Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2005 Oct; 56(4):329-36.
Score: 0.015